Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-21-042767
Date:2021-06-22
Issuer: CRINETICS PHARMACEUTICALS, INC. (CRNX)
Original Submission Date:

Reporting Person:

OKEY STEPHANIE
C/O CRINETICS PHARMACEUTICALS, INC.
10222 BARNES CANYON RD, BLDG 2 SAN DIEGO, CA 92121

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 20.23 2021-06-22 deemed execution date A 17,500 (a) 2031-06-21 common stock 17,500 $20.23 17,500 direct
Footnotes
IDfootnote
f1 the entire number of shares subject to this option become fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the issuer's stockholders, subject to the reporting person's continued service on the board of directors of the issuer through such vesting date.
WhaleWisdom Logo

Elevate your investments